Werewolf Therapeutics Inc Asset Resilience Ratio

Latest as of September 2024: 0.87%

Werewolf Therapeutics Inc asset resilience ratio. Werewolf Therapeutics Inc (HOWL) has an Asset Resilience Ratio of 0.87% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Werewolf Therapeutics Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$1.22 Million

Cash + Short-term Investments

Total Assets

$140.04 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Werewolf Therapeutics Inc (None–None)

Asset resilience ratio of Werewolf Therapeutics Inc from None to None. This chart shows how Werewolf Therapeutics Inc's Asset Resilience Ratio has changed over time. Read Werewolf Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Werewolf Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Werewolf Therapeutics Inc balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.22 Million	0.87%
Total Liquid Assets	$1.22 Million	0.87%

Asset Resilience Insights

Limited Liquidity: Werewolf Therapeutics Inc maintains only 0.87% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Werewolf Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Werewolf Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Chengdu Easton Biopharmaceuticals Co Ltd SHG:688513	Biotechnology	35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Achieve Life Sciences Inc F:SP4P	Biotechnology	3.60%

Werewolf Therapeutics Inc Asset Resilience Ratio by Year (None–None)

Werewolf Therapeutics Inc asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Werewolf Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Werewolf Therapeutics Inc

NASDAQ:HOWL USA Biotechnology

Market Cap

$51.03 Million

Market Cap Rank

#21965 Global

#4899 in USA

Share Price

$1.05

Change (1 day)

+6.49%

52-Week Range

$0.31 - $1.22

All Time High

$20.31